The effects of statins on blood pressure in normotensive or hypertensive subjects - A meta-analysis of randomized controlled trials

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2816-2824

  Banach, Maciej ^a   Nikfar, Shekoufeh ^b,c   Rahimi, Roja ^d   Bielecka Dabrowa, Agata ^a   Pencina, Michael J ^e   Mikhailidis, Dimitri P ^f   Narkiewicz, Krzysztof ^g   Rysz, Jacek ^a   Ray, Kausik K ^h   Abdollahi, Mohammad ^d  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e BOSTON UNIVERSITY   (United States)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^g MEDICAL UNIVERSITY OF GDANSK   (Poland)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Blood pressure; Hypertension; Meta analysis; Statins; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; CERIVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; FOSINOPRIL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NITRATE; PRAVASTATIN; SIMVASTATIN;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; EFFECT SIZE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; DRUG EFFECTS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BLOOD PRESSURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84885582969     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.068     Document Type: Article

References (47)

1. M. Banach, D.P. Mikhailidis, S.E. Kjeldsen, and J. Rysz Time for new indications for statins? Med Sci Monit 15 2009 MS1 MS5
2. P. Strazzullo, S.M. Kerry, A. Barbato, M. Versiero, L. D'Elia, and F.P. Cappuccio Do statins reduce blood pressure?: A meta-analysis of randomized, controlled trials Hypertension 49 2007 792 798
3. M. Stepien, M. Banach, D.P. Mikhailidis, A. Gluba, S.E. Kjeldsen, and J. Rysz Role and significance of statins in the treatment of hypertensive patients Curr Med Res Opin 25 2009 1995 2005
4. J.I. Osende, M. Ruiz-Ortega, L.M. Blanco-Colio, and J. Egido Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study Nephrol Dial Transplant 19 2004 528 531
5. N. Katsiki, D.P. Mikhailidis, and M. Banach Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels J Hypertens 29 2011 2493 2494
6. L. Kalinowski, L.W. Dobrucki, and T. Malinski Cerivastatin potentiates nitric oxide release and eNOS expression through inhibition of isoprenoids synthesis J Physiol Pharmacol 53 2002 585 595
7. S. Morikawa, W. Takabe, and C. Mataki The effect of statins on mRNA levels of genes related to inflammation, coagulation and vascular constriction in HUVEC. Human umbilical vein endothelial cells J Atheroscler Thromb 9 2002 177 183
8. U. Laufs, K. Gertz, U. Dirnagl, M. Bohm, G. Nickenig, and M. Endres Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischaemic stroke in mice Brain Res 942 2002 23 30
9. O. Hernandez-Perera, D. Perez-Sala, and J. Navarro-Antolin Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells J Clin Invest 101 1998 2711 2719
10. S. John, M.P. Schneider, C. Delles, J. Jacobi, and R.E. Schmeider Lipid independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients Am Heart J 149 2005 473
11. G.A. Ferreira, T.P. Navarro, R.W. Telles, L.E. Andrade, and E.I. Sato Atorvastatin therapy improves endothelial-dependent vasodilatation in patients with systemic lupus erythematosus: an 8 week controlled trial Rheumatology 46 2007 1560 1565
12. J. Kowalski, M. Barylski, M. Banach, J. Grycewicz, R. Irzmański, and L. Pawlicki Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention J Cardiovasc Pharmacol 48 2006 143 147
13. Y. Rikitake, S. Kawashima, and S. Takeshita Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits Atherosclerosis 154 2001 87 96
14. U. Aydin, M. Ugurlucan, and F. Gungor Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model Angiology 60 2009 370 377
15. N. Glorioso, C. Troffa, and F. Filigheddu Effect of the HMGCoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia Hypertension 34 1999 1281 1286
16. T. Ikeda, J. Sakurai, and D. Nakayama Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugs Am J Hypertens 17 2004 502 506
17. R. Agarwal Effects of statins on renal function Mayo Clin Proc 82 2007 1381 1390
18. A. Gluba, J. Rysz, and M. Banach Statins in patients with chronic kidney disease: why, who and when? Expert Opin Pharmacother 11 2010 2665 2674
19. G. Parati, G. Bilo, and G. Mancia Prognostic and diagnostic value of ambulatory blood pressure monitoring S. Oparil, M.A. Weber, Hypertension: companion to Brenner & Rector's 'The kidney' 2005 Elsevier Saunders
20. A. Jadad Randomised controlled trials: a user's guide 1998 BMJ Books London
21. J. Lewandowski, M. Siński, and J. Bidiuk Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia Hypertens Res 33 2010 1038 1043
22. A.M. Kuklińska, B. Mroczko, and W.J. Musiał Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress Pharmacol Rep 62 2010 883 890
23. G. Mancia, G. Parati, and M. Revera Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial BMJ 340 2010 c1197
24. C. Manisty, J. Mayet, and R.J. Tapp ASCOT Investigators. Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT) Hypertension 54 2009 1009 1013
25. M. Tonelli, F. Sacks, M. Pfeffer, F. Lopez-Jimenez, G.S. Jhangri, and G. Curhan Effect of pravastatin on blood pressure in people with cardiovascular disease J Hum Hypertens 20 2006 560 565
26. M. Kanbay, A. Yildirir, and H. Bozbas Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients Ren Fail 27 2005 297 303
27. B.M. Balletshofer, S. Goebbel, and K. Rittig Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes - a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial Exp Clin Endocrinol Diabetes 113 2005 324 330
28. G. Derosa, A. Mugellini, L. Ciccarelli, and R. Fogari Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both on anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet Clin Ther 25 2003 1107 1122
29. S. Mondillo, P. Ballo, and R. Barbati Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease Am J Med 114 2003 359 364
30. D.J. Jenkins, C.W. Kendall, and A. Marchie Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein JAMA 290 2003 502 510
31. T.M. Lee, T.F. Chou, and C.H. Tsai Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation J Cardiovasc Pharmacol 40 2002 868 874
32. J. Raison, A. Rudnichi, and M.E. Safar Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study J Hum Hypertens 16 2002 705 710
33. T. Nakamura, C. Ushiyama, K. Hirokawa, S. Osada, N. Shimada, and H. Koide Effect of cerivastatin on urinary albumin excretion and plasma endothelin-1 concentrations in type 2 diabetes patients with microalbuminuria and dyslipidemia Am J Nephrol 21 2001 449 454
34. C. Borghi, M.G. Prandin, F.V. Costa, S. Bacchelli, D. Degli Esposti, and E. Ambrosioni Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia J Cardiovasc Pharmacol 35 2000 549 555
35. A.A. Bak, J. Huizer, P.A. Leijten, H. Rila, and D.E. Grobbee Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease J Intern Med 244 1998 371 378
36. C.J. O'Callaghan, H. Krum, and E.L. Conway Short term effects of pravastatin on blood pressure in hypercholesterolaemic hypertensive patients Blood Press 3 1994 404 406
37. E. Hommel, P. Andersen, and M.A. Gall Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy Diabetologia 35 1992 447 451
38. I.F. McDowell, M. Smye, and T. Trinick Simvastatin in severe hypercholesterolaemia: a placebo controlled trial Br J Clin Pharmacol 31 1991 340 343
39. P. Strazzullo, A. Barbato, and F. Galletti Blood pressure reduction with statins: a metaanalysis of randomized controlled trials J Hypertens 24 2006 S151
40. J.F. Plehn, B.R. Davis, and F.M. Sacks Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) Study Circulation 99 1999 216 223
41. P.S. Sever, B. Dahlöf, and N.R. Poulter ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Lancet 361 2003 1149 1158
42. P.S. Sever, N.R. Poulter, and B. Dahlof ASCOT Investigators. The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extender observations 2 years after trial closure Eur Heart J 29 2008 499 509
43. M. Rizzo, G. Montalto, and M. Banach The effects of statins on blood pressure: current knowledge and future perspectives Arch Med Sci 8 2012 1 3
44. F.H. Messerli, L. Pinto, and S.S. Tang Impact of systemic hypertension on the cardiovascular benefits of statin therapy - a meta-analysis Am J Cardiol 101 2008 319 325
45. A.M. Tycinska, J. Janica, and B. Mroczko Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction Arch Med Sci 7 2011 955 962
46. B.A. Golomb, J.E. Dimsdale, H.L. White, J.B. Ritchie, and M.H. Criqui Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial Arch Intern Med 168 2008 721 727
47. D. Nikolic, S. Nikfar, and P. Salari Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials Curr Med Res Opin 29 5 2013 May 435 451